Internal Medicine (Tokyo, 1992) 2008-01-01

Iatrogenic hyperadrenocorticism and steatohepatitis caused by unapproved medicine.

Akira Kitahara, Kumiko Saga, Shigeki Koide, Tomoaki Isobe, Yutaka Oki, Hirotoshi Nakamura

Index: Intern. Med. 47(13) , 1231-6, (2008)

Full Text: HTML

Abstract

A 54-year-old man experienced weight gain. He was diagnosed as having hyperglycemia, hypertension and liver damage. Liver biopsy showed steatohepatitis. We initially suspected him as having hyperadrenocorticism. However, both adrenocorticotropic hormone and cortisol levels were low. Later, it was revealed that he took medicine to relieve his gonalgia. His hyperglycemia, hypertension and liver damage improved after he discontinued taking the medicine. An analysis of this medicine showed that it contained desoximetasone, a glucocorticoid compound that had not been approved for medical use in Japan. To adequately diagnose clinical conditions, it is necessary to survey the patient's medicinal history in detail.

Related Compounds

  • Desoximetasone

Related Articles:

The effects of dissociated glucocorticoids RU24858 and RU24782 on TPA-induced skin tumor promotion biomarkers in SENCAR mice.

2014-06-01

[Mol. Carcinog. 53(6) , 488-97, (2014)]

Photosensitivity to desoximetasone emollient cream.

1988-12-01

[Arch. Dermatol. 124(12) , 1870-1, (1988)]

Rapid assay of the anti-inflammatory activity of topical corticosteroids by inhibition of a UVA-induced neutrophil infiltration in hairless mouse skin. II. Assessment of name brand versus generic potency.

1994-01-01

[Acta Derm. Venereol. 74(1) , 18-9, (1994)]

Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.

2008-01-01

[Skin Pharmacol. Physiol. 21(3) , 181-7, (2008)]

Spectrophotometric determination of desoximetasone in ointment using 1,4-dihydrazinophthalazine.

1996-06-01

[J. Pharm. Biomed. Anal. 14(8-10) , 947-50, (1996)]

More Articles...